- Home
- NYMTN vs CINGW Comparison
NYMTN vs CINGW Comparison
Compare NYMTN & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMTN
- CINGW
- Stock Information
- Founded
- NYMTN N/A
- CINGW N/A
- Country
- NYMTN United States
- CINGW United States
- Employees
- NYMTN 79
- CINGW 13
- Industry
- NYMTN Real Estate Investment Trusts
- CINGW Biotechnology: Pharmaceutical Preparations
- Sector
- NYMTN Real Estate
- CINGW Health Care
- Exchange
- NYMTN Nasdaq
- CINGW Nasdaq
- Market Cap
- NYMTN N/A
- CINGW N/A
- IPO Year
- NYMTN N/A
- CINGW 2021
- Fundamental
- Price
- NYMTN $22.49
- CINGW $0.04
- Analyst Decision
- NYMTN
- CINGW
- Analyst Count
- NYMTN 0
- CINGW 0
- Target Price
- NYMTN N/A
- CINGW N/A
- AVG Volume (30 Days)
- NYMTN N/A
- CINGW N/A
- Earning Date
- NYMTN N/A
- CINGW N/A
- Dividend Yield
- NYMTN N/A
- CINGW N/A
- EPS Growth
- NYMTN N/A
- CINGW N/A
- EPS
- NYMTN N/A
- CINGW N/A
- Revenue
- NYMTN N/A
- CINGW N/A
- Revenue This Year
- NYMTN N/A
- CINGW N/A
- Revenue Next Year
- NYMTN N/A
- CINGW N/A
- P/E Ratio
- NYMTN N/A
- CINGW N/A
- Revenue Growth
- NYMTN N/A
- CINGW N/A
- 52 Week Low
- NYMTN N/A
- CINGW N/A
- 52 Week High
- NYMTN N/A
- CINGW N/A
- Technical
- Relative Strength Index (RSI)
- NYMTN 41.81
- CINGW N/A
- Support Level
- NYMTN $22.20
- CINGW N/A
- Resistance Level
- NYMTN $22.72
- CINGW N/A
- Average True Range (ATR)
- NYMTN 0.24
- CINGW 0.00
- MACD
- NYMTN -0.01
- CINGW 0.00
- Stochastic Oscillator
- NYMTN 36.25
- CINGW 0.00
About NYMTN New York Mortgage Trust Inc. 8.00% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About CINGW Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.